10-Bromo-9-fluoro-2-iodo-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepine

Catalog No. :
ACMNKW502
CAS No. :
1401305-32-5
Molecular Formula :
C11H7BrFIN2O
Molecular Weight :
409.00

IUPAC Name:10-bromo-9-fluoro-2-iodo-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepine

10-Bromo-9-fluoro-2-iodo-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$1341.00Login to see priceInquiryInquiry
1g97%$2195.00Login to see priceInquiryInquiry
5g97%$3635.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name10-Bromo-9-fluoro-2-iodo-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepine
IUPAC Name10-bromo-9-fluoro-2-iodo-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepine
MDL No.MFCD29920974
Molecular FormulaC11H7BrFIN2O
Molecular Weight409.00
SMILESIC1=CN2CCOC3=CC(F)=C(Br)C=C3C2=N1
InChI KeyPJELOMRFWGRHOI-UHFFFAOYSA-N
Synonym10-BROMO-9-FLUORO-2-IODO-5,6-DIHYDROBENZO[F]IMIDAZO[1,2-D][1,4]OXAZEPINE;Imidazo[1,2-d][1,4]benzoxazepine, 10-bromo-9-fluoro-5,6-dihydro-2-iodo-
CAS No.1401305-32-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACMNKW502 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACMNKW502 route product structure diagram
    ACMNKW5021401305-32-5
Inquiry

2. ACMNKW502 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACMNKW502 route product structure diagram
    ACMNKW5021401305-32-5
Inquiry

Comments (0)